OptumInsight, 12525 Technology Drive, Eden Prairie, MN 55344, USA.
Osteoporos Int. 2013 Mar;24(3):825-33. doi: 10.1007/s00198-012-2067-x. Epub 2012 Jul 10.
The purpose of this study was to examine the medical costs and the management of osteoporosis in the 12 months after a closed fracture for men aged ≥ 45 years. The mean medical cost per fracture was high ($6,078-$30,900), and osteoporosis management post fracture was inadequate in the majority of men.
This study was conducted in order to examine the medical costs following fracture in males and the management of osteoporosis post fracture.
Administrative claims from a large, national health plan were analyzed. Men ≥ 45 years were included if they had ≥ 1 medical claim for a new closed fracture between January 1, 2005 and December 31, 2008. Commercially insured (COM) and Medicare Advantage Plan (MAP) members were analyzed separately. Costs were calculated as paid amounts and adjusted to 2010 dollars. Both the differences between the individual patients' 12-month pre-fracture and 12-month post-fracture costs and the costs directly attributed to the fracture were reported. The prevalence of dual-energy X-ray absorptiometry (DXA) scan and/or osteoporosis pharmacotherapy treatment was evaluated in the 12 months post fracture.
We identified 18,917 (COM, 16,191; MAP, 2,726) men with new closed fractures. Non-hip, non-vertebral fractures (NHNV) were the most common fracture in both COM and MAP populations. Fracture costs ranged from $7,121 to $15,830 for vertebral fractures, from $22,601 to $30,900 for hip fractures, and from $6,078 to $8,344 for NHNV fractures. In the COM and MAP populations, respectively, 8.5 and 15.5 % had a DXA scan and/or osteoporosis pharmacotherapy in the 12 months following the fracture.
Healthcare costs associated with fractures in men are substantial. About 1 in 12 men ≥ 45 years in the COM population were provided adequate follow-up for osteoporosis post fracture. While this rate improved to about one in six men in the MAP population, osteoporosis management in men post fracture is far from optimal.
本研究旨在探讨≥45 岁男性闭合性骨折后 12 个月的医疗费用及骨质疏松管理情况。大多数男性骨折后医疗费用高（6078-30900 美元），且骨质疏松管理不足。
本研究旨在检查男性骨折后的医疗费用以及骨折后骨质疏松的管理情况。
分析来自大型全国健康计划的行政索赔数据。2005 年 1 月 1 日至 2008 年 12 月 31 日期间，≥45 岁且至少有 1 次新闭合性骨折医疗索赔的患者被纳入研究。分别分析商业保险（COM）和医疗保险优势计划（MAP）患者。费用以支付金额计算，并调整为 2010 年美元。报告了每位患者骨折前 12 个月和骨折后 12 个月的差异，以及直接归因于骨折的费用。评估了骨折后 12 个月内双能 X 线吸收测定法（DXA）扫描和/或骨质疏松症药物治疗的发生率。
共确定了 18917 例（COM16191 例，MAP2726 例）新发闭合性骨折男性患者。非髋部、非椎体骨折（NHNV）在 COM 和 MAP 人群中均最常见。COM 和 MAP 人群的椎体骨折费用分别为 7121-15830 美元、髋部骨折费用为 22601-30900 美元、NHNV 骨折费用为 6078-8344 美元。在 COM 和 MAP 人群中，骨折后 12 个月分别有 8.5%和 15.5%的患者接受了 DXA 扫描和/或骨质疏松症药物治疗。
男性骨折相关医疗费用较高。COM 人群中约 12%的≥45 岁男性骨折后接受了充分的骨质疏松随访，而 MAP 人群中这一比例约为 1/6，但男性骨折后骨质疏松管理仍远未达到理想状态。
